Table 2 Baseline characteristics of participants in respective trials. (N/a- data not available).
Author | Age mean (SD and/or range) years | Female:male (% female) | Mean BMI (SD) | |||
|---|---|---|---|---|---|---|
| Â | Treatment group | Control group | Treatment group | Control group | Treatment group | Control group |
Abt et al [21] | 56.5 | 57.4 | 11:6 (64.7) | 9:6 (60) | 30.1 | 28.5 |
Buch et al [27] | 50.4 (10.3, 26–69) | 53.0 (9.7, 31–72) | 61:14 (81.3) | 46:26 (63.9) | 28.9 | 28.5 |
Buchbinder et al [10] | 52.2 (12.8) | 54.2 (12.0) | 46:3 (57.5) | 47:3 (58.0) | 29.5 | 28.9 |
Cosentino et al [33] | 55.6 (45–68) | 18:12 (60.0) | 25:5 (83.3) | N/a | N/a | |
Haake et al [11] | 53.1 (10.8) | 52.9 (10.8) | 98:37 (72.6) | 106:30 (77.9) | 29.4 (4.9) | 29.7 (4.8) |
Krischek et al [22] | 54.0 | 55.0 | (56.0) | (72.0) | N/a | N/a |
Ogden et al [28] | 49.6 (20–79) | 171 (65.9) | N/a | N/a | ||
Rompe et al [32] | 44.0 (26–61) | 49.0 (31–63) | 21:29 (42.0) | 20:30 (40.) | N/a | N/a |
Rompe et al [30] | 47.0 (26–61) | 51.0 (31–58) | 5:10 (33.3) | 6:9 (40) | N/a | N/a |
Rompe et al [31] | 43.0 (32–59) | 40.0 (30–61) | 10:12 (45.5) | 13:10 (56.5) | N/a | N/a |
Speed et al [12] | 51.7 (25–76) | 52.5 (30–73) | 26:20 (56.5) | 25:17 (59.5) | N/a | N/a |